Botanical and Plant-derived Drugs Market Forecast to 2027

LONDON, January 5, 2018 /PRNewswire/ --

Prospects for Leading Companies in Steroids, Phenols, Terpenes, Glycosides and Others, Sativex, Marinol Nabilone, Dexanabinol, CT-3, Cannabinor, HU 308, HU 331, Rimonabant, Taranabant

The global botanical and plant-derived drugs market is expected to grow at a CAGR of 6.8% in the first half of the forecast period. In 2016, the phenols submarket held 30.2% of the global botanical and plant-derived drugs market.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 70 tables and 82 figures- all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global botanical and plant-derived drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope 

• Global Botanical and Plant-derived Drugs Market forecast to 2027

• This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by type:
- Steroids
- Phenols
- Terpenes
- Glycosides
- Others

This report provides a SWOT analysis for each submarket.

• This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by application:
- Hormone Diseases
- Infectious Diseases
- Pain & Central Nervous System Disorders
- Cardiovascular & Metabolic Diseases
- Respiratory & Oncology Diseases

• Our work also shows individual revenue forecasts to 2027 for these regional and national markets
- North America: US & Canada
- Europe: Germany, France, the UK, Italy, Spain, Rest of Europe
- Asia-Pacific: China, Japan, India, Rest of APAC
- Latin America: Brazil, Mexico, Rest of Latin America
- Middle East & Africa: Saudi Arabia, South Africa, Rest of Middle East & Africa

Each regional market if further segmented by type and by application. 

• This report discusses several brands, including:
- Sativex (GW Pharmaceuticals)
- Marinol (Unimed Pharmaceuticals)
- Nabilone / Cesamet (Valeant Pharmaceuticals)
- Dexanabinol (Solvay Pharmaceuticals, acquire by Abbott Laboratories)
- CT-3 (Indevus Pharmaceuticals)
- Cannabinor (Pharmos)
- HU 308 (Pharmos)
- HU 331 (Cayman Chemical)
- Rimonabant / Acomplia (Sanofi-Aventis)
- Taranabant / MK-0364 (Merck & Co.)

• This report assesses several leading companies that manufacture and market botanical and plant-derived drugs, including:
- Abbott Laboratories
- Bayer AG
- Eli Lilly
- Johnson & Johnson
- Novartis AG
- Pfizer, Inc.
- Bristol-Myers Squibb (BMS)
- Medigene AG

• This report also discusses the Drivers and Restraints of the global botanical and plat derived-drugs market.

Visiongain's study is for everybody needing commercial analyses for the global botanical and plat derived-drugs market. You will find data, trends and predictions. Please order our report now.

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com (+44-(0)-20-7336-6100) or refer to our website:

https://www.visiongain.com/Report/2092/Botanical-and-Plant-Derived-Drugs-Market-Forecast-to-2027

List of Companies and Organisations Mentioned 

Abbott Laboratories

AbCellera Biologics, Inc.

Abott Laboratories

Accelis Pharma

Alere, Inc.

Almirall, S.A.

Array BioPharma

Arzneimittelwerk

Asia Journal of Cancer Prevention

Baader Bank AG

Baxter International

Bayer AG

Bristol-Myers Squibb

Canadian Cancer Society

Cancer Research UK

Cayman Chemical

Centre for Chronic Disease Control & Prevention

China's Ministry of Health (MOH)

Eli Lilly and Company

EUFETS GmbH

European Medicines Agency

European PD Association (EPDA)

European Union

Food and Drug Administration (FDA)

Fougera Pharmaceuticals, inc.

Guggenheim Securities, LLC

GW Pharmaceuticals

Hospira

Indevus Pharmaceuticals

Indian Council of Medical Research (ICMR)

Institute for Health Metrics and Evaluation

International Agency for Research on Cancer (IARC)

Istat

Janssen Products, LP

Johnson & Johnson

McKinsey & Co

Medigene AG

Merck

Mitsui Norin Co. Ltd

National Center for Biotechnology Information (NCBI)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Health

National Kidney Foundation

Novartis International AG

Organisation for Economic Co-operation and Development (OECD)

Otsuka Pharmaceutical

Paladin Labs Inc.

Pfizer, Inc.

Pharmos

Press Information Bureau

Rome Foundation

Sandoz Inc.,

Sanofi S.A.

Solvay Pharmaceuticals

Solvay Pharmaceuticals

The United Nations

The World Bank

Trout Capital LLC

UNICANCER

Unimed Pharmaceuticals

US. National Cancer Institute

Valeant Pharmaceuticals International

World Health Organization

World Heart Federation

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

SOURCE Visiongain